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Abstract 
Purpose: To assess the validation of a novel control selection design by comparing the 
consistency between the new design and a routine design in a large case-control study that 
was incorporated into a nationwide mortality survey in China. 
Methods: A nationwide mortality study was conducted during 1989–1991. Surviving 
spouses or other relatives of all adults who died during 1986–1988 provided detailed infor-
mation about their own as well as the deceased person’s smoking history. In this study, 
130,079 males who died of various smoking-related cancers at age 35 or over were taken as 
cases, while 103,248 male surviving spouses (same age range with cases) of women who died 
during the same period and 49,331 males who died from causes other than those related to 
smoking were used as control group 1 and control group 2, respectively. Consistency in the 
results when comparing cases with each of the control groups was assessed. 
Results: Consistency in the results was observed in the analyses using different control 
groups although cancer deaths varied with region and age. Equivalence could be ascertained 
using a 15% criterion in most cancer deaths which had high death rates in urban areas, but 
they were uncertain for most cancers in rural areas irrespective of whether the hypothesis 
testing showed significant differences or not. 
Conclusions: Sex-matched living spouse control design as an alternative control selection 
for a case-control study is valid and feasible, and the basic principles of the equivalence study 
are also supported by epidemiological survey data. 
Key words: case-control studies; epidemiologic methods; comparative study; smoking; Chinese 
men. 
Introduction 
One of the most important measures for ascer-
taining the impact of tobacco on a population is the 
estimation of the mortality attributable to its use. To 
measure this, a number of indirect methods of quan-
tification are available.1-5 However, although different 
methodologies are widely used, their methodological 
foundations are all quite similar. Mainly they are 
based on the calculation of the proportional attribut-
able fraction. Thus, one of the limitations of the esti-
mation remained, because the proportional mortality Int. J. Med. Sci. 2009, 6 
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analysis cannot estimate mortality from the causes of 
death similar to those in the reference group. To im-
prove the existing calculations, a novel control group 
design was introduced in a previous study,6 which 
replaced the regular reference group by using the 
same sex surviving spouses of deceased people to 
calculate the mortality risk rate. However, one ques-
tion has been raised simultaneously, is it accurate and 
validation? 
Although most clinical study activities are aimed 
at showing that equivalence can also be claimed for 
generic versions of innovator drugs and for such di-
verse entities as medical protocols, surgical tech-
niques and medical devices,7-10 there are no such 
standard criteria for how to evaluate and support 
such equivalence claim in epidemiological survey 
data although many reports,11-13 for example, sug-
gested that several well-designed valid case-control 
studies with consistent results should be helpful in 
policy making when an answer is needed a short time. 
The purpose of this study was to apply the basic 
principles of a population-based case-control study to 
assess the validation of the novel control selection 
design by comparing the consistency between the 
new design and a routine control selection design in a 
large case-control study that was incorporated into a 
nationwide mortality survey in China in 1989–1991. 
As an example, we assessed the hazards of tobacco 
use on smoking-related cancer deaths in Chinese 
adult men. We also offer specific suggestions that we 
believe are useful in choosing controls within the 
framework of the study principles. 
SUBJECTS AND METHODS 
National Mortality Survey and Case-Control 
Study Design 
In 1989–1991, a large nationwide retrospective 
mortality survey was conducted in China, which in-
volved 103 study areas (24 major cities and 79 coun-
ties) and approximately 1,000,000 adult deaths from 
all causes during the years 1986–1988.1 We defined the 
total population (close to 67 million) from which the 
mortality survey was conducted as the study base. 
Cases and two groups of controls were obtained 
within the study base: 130,079 males who died of 
smoking-related cancers at age 35 or over were de-
fined as cases. These diseases included: malignant 
neoplasm of the lips, oral cavity, and larynx ((ICD-9: 
140–149, 161, 3.9%), esophageal cancer (150, 15.2%), 
stomach cancer (151, 25.9%), liver cancer (155, 22.7%), 
lung cancer (162, 27.2%), pancreatic cancer (157, 2.6%), 
prostate cancer (185, 0.7%), and bladder cancer (188, 
1.8%)). We combined the cancers of ICD-9 Codes 
(140–149,161) into one group named “minor site can-
cers” because the death rates for these cancers were 
too low for separate analysis. Two different control 
groups were selected. The first group was recruited 
using the novel design, which comprised all male 
surviving spouses (same age range with cases) of any 
women who died (any cause of death) during those 
same years. The second control group was chosen 
using the proportional mortality method and com-
prised all men aged 35 or over who died from causes 
other than those related to smoking. These diseases 
included: infectious and parasitic diseases (ICD-9: 
001–009, 020–139, 7.8%), endocrine, metabolic, im-
mune diseases (240–279, 5.6%), blood and 
blood-forming organ diseases (280–289, 0.9%), mental 
disorders (290–319, 3.3%), nervous system diseases 
(320–359, 3.1%), digestive system diseases (520–579, 
27.5%), genitourinary system diseases (580–608, 
10.0%), musculoskeletal and connective tissue dis-
eases (710–739, 0.9%), injury and poisoning (800–897, 
33.1%), and other medical disorders (360–389, 
680–709, 780–796, 7.9%). The selection of controls in 
this study was based on three assumptions: (1) the 
individuals in both control groups had, in 1980, 
smoking habits that were similar to those of the study 
base; (2) there was no significant relationship between 
husband and wife in control group 1 in terms of to-
bacco use; (3) the causes of death in control group 2 
were unrelated to tobacco exposure. Thus two sepa-
rate population-based case-control studies were 
formed within the study base with one group of cases 
and two different control groups. 
The information on smoking history was ob-
tained by interviews. We interviewed informants 
(spouses or other relatives) of all deceased persons 
who described their own smoking habits as well as 
those of their dead partners. These data were used to 
determine whether people had ever smoked before 
1980, a period of time prior to the onset of their dis-
ease. A non-smoker was defined as a person who had 
never smoked during his life or had only smoked in-
frequently at a young age. 
Statistical Methods 
The relative risk (RR) for cancer deaths in smok-
ers and non-smokers was estimated by 
non-conditional logistic regression, adjusted for age 
(5-year age groups) and the area of the residence. 
Confidence intervals (CIs) were used in this 
study, as in clinical trials,7–10 to evaluate the equiva-
lence of the two case-control studies in assessing the 
risk of cancer deaths due to smoking. We first defined 
a range of equivalence as an interval from -δ to δ 
(here, we defined δ=0.15). We then simply checked Int. J. Med. Sci. 2009, 6 
 
http://www.medsci.org 
331
whether the CI centered on the observed ratio of 
2
1
ˆ
ˆ
R R
R R
 (the procedure of calculating CI is listed in 
Appendix) lay entirely between e-δ to e+δ. If it did, 
equivalence was demonstrated; if it did not, there was 
uncertainty regarding equivalence. Because 
δ
δ + ≅1 e (when δ≤ 0.15), for convenience, the range 
of equivalence was replaced by (1 - δ, 1 + δ). Thus the 
limits for equivalence in this study were within 0.85 
and 1.15. 
RESULTS 
There were a total of 130,079 cases and 152,579 
controls (103,248 in control group 1; 49,331 in control 
group 2) in our study. The basic characteristics of the 
cases and controls, and relative risk of smok-
ing-related cancer deaths among smokers by com-
parison cases with each of the two control groups are 
shown in Table 1. Although data show that the rela-
tive risk from smoking was greater for urban males 
than rural males, both study groups revealed a con-
sistent pattern of the effect of smoking on risk of can-
cer deaths. 
TABLE 1. Characteristics of cases and two control groups: 
Population-based case-control study of smoking on risk of 
cancer deaths among Chinese men 1989–1991. 
Controls  Characteristic Cases 
Control 
group 1 
Control 
group 2 
No. of subjects  130,079  103,248  49,331 
Mean age (years)  63.3 ± 10.7† 62.4  ± 11.6  61.0 ± 13.8 
% urban    69.2  69.1  24.6 
% rural    30.8  30.9  75.4 
% smokers (Total)  70.7  59.2  63.4 
n, % smokers (Ur-
ban) 
90,061 (70.1)  71,316 
(57.1) 
12,147 (58.4) 
n, % smokers (Ru-
ral) 
40,018 (71.9)  31,932 
(64.1) 
37,184 (65.1) 
Relative Risk (95%CI)‡ for smoking   
with cases and different controls   
  Urban    1.77 (1.73–1.81)  1.71 (1.65–1.78) 
  Rural    1.44 (1.41-1.49)  1.37 (1.33–1.45) 
% of deaths attributed to smoking 
  Urban   30.5%  29.1%  
 Rural    21.9%  19.4% 
† One standard deviation 
‡ 95% confidence interval 
 
 
Overall, 35.6% of the cancer cases (38.5% urban, 
28.9% rural) were confirmed by pathology, 56.3% 
(55.8% urban, 57.5% rural) were diagnosed by X-ray 
or by CT scan, and 8.1% (5.7% urban, 13.5% rural) 
were diagnosed by clinical experience or by other 
methods. The other methods group included patients 
who could not afford to go to hospital, and when the 
families of these individuals were interviewed, a 
qualified physician provided a diagnosis based on the 
patient’s symptoms. 
The adjusted cancer RRs and their CIs had a high 
degree of overlap (with a small standard error) be-
tween the two control groups in deaths from 
esophagus cancer, stomach cancer, liver cancer, and 
lung cancer (Figure 1) which had high incidence rates 
although the death rates from these cancers varied by 
region and age (data not shown). When data were 
combined to calculate the risk for all men, the RR 
(95%CI) with control groups one and two, respec-
tively, were: 1.96 (1.84–2.08) and 1.88 (1.79–1.97) for 
esophagus cancer; 1.29 (1.23–1.35) and 1.28 (1.24–1.34) 
for stomach cancer; 1.35 (1.31–1.39) and 1.33 
(1.27–1.39) for liver cancer, 2.98 (2.88–3.08) and 2.95 
(2.81–3.09) for lung cancer. However, for other neo-
plasms which had low rates, the discrepancies in CIs 
were increased because of a large standard error, and 
this was particularly true for rural residents. 
The relative risks for cancer deaths between the 
two groups were also examined in subgroups ac-
cording to smoking history (Figure 2-3). The result 
revealed a high consistency with both control groups 
in most subgroups. In particular, with smokers in 
both urban and rural areas, whose most recent habits 
involved only cigarettes, significant dose-response 
relationships were found both in the duration of the 
smoking habit and in daily cigarette consumption. For 
example, in urban men, the RR (95%CI) for daily 
cigarette consumption <10, 10–19, ≥20 cigarettes per 
day, respectively were: study group 1: 1.40 (1.34–1.45), 
1.48 (1.44–1.52), and 2.25 (2.19–2.32); study group 2: 
1.38 (1.29-1.49), 1.42 (1.35–1.50), and 2.12 (2.01–2.22). 
The absolute differences between the two groups in 
RRs ranged from 0.02 to 0.13. Furthermore, the RR 
(95%CI) for those who smoked ≥20 cigarettes each day 
and had been smoking of for <20, 20–34, and 35+ 
years, respectively, were: group 1: 1.73 (1.65–1.82), 
2.26 (2.16–2.36) and 2.53 (2.45–2.62); group 2: 0.98 
(0.90–1.06), 1.94 (1.78-2.12) and 3.06 (2.85–3.28). The 
absolute differences in RRs ranged from 0.32 to 0.75, 
respectively (all trends test, P < 0.001). There was a 
similar trend in rural men, although the RRs were 
smaller than in urban men. 
The equivalence tests with a predefined interval 
(0.85-1.15) for various cancer deaths were shown in 
Figure 4, and the importance of not basing conclu-
sions on statistical significance can also be seen in this 
Figure. Any CI which does not overlap 1.0 corre-
sponds to a statistically significant difference between 
the two control groups. In the data shown for urban 
males, the two estimates could be considered to have Int. J. Med. Sci. 2009, 6 
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equivalence in esophagus cancer, stomach cancer, 
liver cancer, pancreas cancer, lung cancer cancers, and 
cancers on the minor sites, whereas the equivalence is 
uncertain for bladder cancer and prostate cancer al-
though all showed no statistically significant differ-
ence between compared groups. For rural males, no 
equivalence could be ascertained (except for liver 
cancer deaths) irrespective of whether the hypothesis 
testing showing significant differences or not. Fur-
thermore, when we combined all cancers to test 
equivalence again, the results revealed equivalence in 
the two control groups for both urban and rural 
males, with no statistically significant difference in 
total cancer deaths between the compared groups. 
 
 
FIGURE 1. Smoker vs. non-smoker cancer death RR ratios in various cancer sites in males ages 35 and over, 1986–1988 
in urban and rural areas. †RR1 and RR2 denote relative risks calculated with study group1 and study group 2, respectively. Int. J. Med. Sci. 2009, 6 
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FIGURE 2. Proportion of smoking by different smoking histories and relative risk for smoker vs. non-smoker cancer death 
in various subgroups. Urban males ages 35 and over, 1986–1988 in China. † RR1 and RR2 denote relative risks calculated 
with study group1 and study group 2, respectively. 
 
 
 
 
FIGURE 3. Proportion of smoking by different smoking histories and relative risk for smoker vs. non-smoker cancer death 
in various subgroups. Rural males ages 35 and over, 1986–1988 in China. Int. J. Med. Sci. 2009, 6 
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FIGURE 4. The results of using the confidence interval approach: -δ (15%) to +δ is the pre-specified range of equivalence: 
the horizontal lines correspond to possible outcomes expressed as confidence intervals, with the associated significance test 
results shown on the left: (1) denotes equivalence; (2) denotes uncertainty. 
 
Discussion 
To our knowledge, this is the first nationwide 
study comparing different control groups in a popu-
lation-based case-control study, to assess the associa-
tion between smoking and death from various cancers 
in Chinese men. It shows that tobacco smoking is as-
sociated with a moderate, but highly significant, in-
crease in the risk of death from various cancers. The 
consistency in results was observed in the analyses 
using different control groups although in most cases 
the value of RR1 revealed a bit greater than the value 
of RR2. Our study showed that equivalence can be 
ascertained using the 15% criterion in those cancers 
which are very common in urban areas, but they are 
uncertain for most cancers in rural areas irrespective 
of whether the hypothesis testing showed significant 
differences or not between the two control groups. 
Using sex-matched spouses as controls is an in-
novative design, and it is possible to produce ap-
proximately random samples of the base population, 
because all deceased people were approximately at 
random within the study base, as were their spouses. 
The strengths of this design are: (1) it is possible to 
provide an alternative method to give accurate esti-
mate of early smoking-attributable mortality within a 
nationwide level; (2) we may assess more relation-
ships between one or more exposures and various 
causes of death at one time, and use of a single control 
group for more than one case series can lead to saving 
of money and time;11-12 (3) all possible confounding 
factors (known or unknown) and interaction effects 
between groups are balanced by using large matching 
populations. In contrast, prospective studies take 
years to mature, whereas retrospective methods re-
quire much less time.12  
Three issues have been considered regard with 
the valid of our results: First, it should be noted, if 
there is a strong association of smoking habits be-
tween couples, the risks may be somewhat attenu-
ated. In this study, the Kappa coefficient of agreement 
test on smoking habits of couples were 0.076 in urban 
areas, and 0.163 in rural areas, indicating a very weak 
association between couple’s smoking habit. Second, 
we compared the prevalence of smoking between 
male living spouses of women who died of any cause 
and those spouses of women who died of some other 
causes other than smoking related causes. The preva-
lence of smoking were 57.1% and 57.8%, respectively, 
for urban male spouses, 64.1% and 63.6%, respectively Int. J. Med. Sci. 2009, 6 
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for rural male spouses indicating the relative risk 
analyses will not exaggerate the hazard of tobacco. 
The third issue involves the validity of smoking data 
obtained from surrogates. There are few former 
smokers in China (except those who stopped because 
they were ill),14-16 and family members were generally 
confident about whether the dead person had 
smoked, although they were sometimes uncertain of 
the age when smoking began. A validity study in 
Shanghai was conducted where the surviving spouse 
was the informant and both husband and wife had 
reported their smoking habits in the early 1980s.17 
Information obtained from the spouse on the hus-
band’s smoking habits was highly consistent with 
information provided directly by the husband. In this 
study, the very similar trends exit between two 
groups in different subgroups (Figure 2-3) indicating 
there is no obvious disagreement in smoking history 
reported by proxy or by self-report. 
In this study, we attempt to apply the equiva-
lence approach to assess the consistency of different 
control selections with a control group determined by 
the proportional mortality method as an ‘active con-
trol’ to evaluate the accuracy and feasibility of the 
new control design. Although the dependence of RR1 
and RR2 may have some extended the length of CIs, 
which could lower the precise of CIs, some strengths 
are still addressed:7,13,18 First, a large adequate sample 
size in each compared group can insure consistency 
between the initial design and final analysis based on 
symmetric CIs for estimation using a normal CI ap-
proach. Second, a large adequate sample size in each 
compared group will make a high probability (1- β, β 
is type II error) to insure that the upper/low limit of 
CIs will not excess the selected criterion (±15%), 
i.e.,
β δ α − = ≤ − + − − 1 ] ) ˆ ln ˆ (ln ˆ ln ˆ Pr[(ln 2 1 1 2 1 R O R O Var z R O R O
, where 1-β is statistical power.19 Third, we selected 
control group 2 as an ‘active control’ group which is 
reliant on an implicit ‘historical control assumption’. 
One cannot automatically assume that the active con-
trol group will be effective under a new set of study 
conditions by virtue of the fact that it was previously 
proven to be efficacious for a given indication. Our 
findings revealed that better equivalence exists in 
urban than in rural areas, and for cancers with a high 
death rate than for ‘rare’ cancers. The possible expla-
nations may be: (1) some rare cancer death rates are 
too low to be stable; (2) a difference in the accuracy of 
certificated cause of death between urban and rural 
counties; (3) large fluctuations in Chinese social cir-
cumstances during the decades before 1980, with 
large changes in cigarette sales per adult, meaning 
that middle-aged cigarette smokers who died in 
1986–1988 were unlikely to have had consistent to-
bacco consumption since early adult life: this is par-
ticularly true in large rural areas. Our findings also 
confirmed the fact that the conventional statistical 
significance test has little relevance in equivalence 
testing. Failure to detect a difference between two RRs 
does not imply equivalence, and a statistically sig-
nificant difference does not mean it is not equivalent. 
It should be noted that absolute equivalence can never 
be demonstrated, and it is only possible to assert that 
the true difference is unlikely to be outside a range, 
which depends on the size of the trial and specified 
probabilities of error.13,18 
In the methodological areas of control selection, 
it is widely accepted that the inclusion of multiple 
control groups selected by different criteria is prefer-
able to only one control group.20-23 Multiple control 
groups provide checks on potential biases, and afford 
the opportunity to demonstrate consistency in the 
findings. In our study, a series of consistent patterns 
of results was obtained from control group 1 and 
group 2. Although selection biases could produce 
similar but erroneous results, this is most unlikely 
because two control groups were selected by com-
pletely different means in this study. However, it 
should be noted that there is no ‘gold standard’ in 
epidemiological surveys although we selected con-
trols by the proportional mortality method as the ‘ac-
tive controls.’ Any control selection has its own 
strength or weakness. We used the proportional 
mortality method, for example, to create an ‘active 
control,’ and the main strengths of such controls is 
that the criteria for eligible controls can be established 
conveniently; any omissions typically will not lead to 
selection bias, since the accuracy of the system for 
registering deaths from most causes is unlikely to 
vary substantially with cause of death.11,18 Further-
more, any recall bias affecting assessment of smoking 
habits in the cases should similarly affect assessment 
of smoking habits in the control group,1 however, 
insisting on a dead control group violates the study 
base principle, since the base consists of living sub-
jects. In the same situation, when we use a 
sex-matched living spouse control design, we may 
explore smoking hazards more widely (known or 
unknown) and accurately. However, when informa-
tion is obtained from a surrogate because the case is 
dead, using a living control sampled properly from 
the base can breach the principle of comparable ac-
curacy.11 
Some limitations of this study must also be con-
sidered when interpreting the results. First, only 90% 
of deaths in the study base were recruited, thus selec-Int. J. Med. Sci. 2009, 6 
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tion bias may have some effect on our results. Second, 
5.7% of urban and 13.5% of rural cancer deaths in our 
study were diagnosed only by clinical experience, or 
inference after dying, which may result in misclassi-
fication, and this is particularly true in rural areas, 
although our design included a greater urban popu-
lation  than rural population, which countered the 
difference in accuracy of the death certificate. Third, 
social class, which is also associated with both smok-
ing and cancer deaths, was not measured in this 
study, and the separate calculation of risk patterns in 
urban and rural areas was used as a surrogate analy-
sis by socioeconomic status. 
In conclusion, the basic principles of equivalence 
are also supported by epidemiological survey data. 
The sex-matched living spouse control design as an 
alternative control selection for a nationwide popula-
tion-based case-control study is valid and feasible, 
and can produce highly acceptable research results for 
a fixed expenditure of time and resources. 
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Appendix 
Fig. 5. The procedure of calculating 95%CI for RR1/RR2 
 